Works matching IS 10837159 AND DT 2013 AND VI 18 AND IP 6
Results: 28
Erratum: Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy.
- Published in:
- 2013
- Publication type:
- Journal Article
Personalized Medicine: Hype or Reality.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Phase II Trial of Neoadjuvant Docetaxel and CG1940/CG8711 Followed by Radical Prostatectomy in Patients With High-Risk Clinically Localized Prostate Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 687, doi. 10.1634/theoncologist.2011-0234
- By:
- Publication type:
- Article
The Potential of Helical Tomotherapy in the Treatment of Head and Neck Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 697, doi. 10.1634/theoncologist.2012-0424
- By:
- Publication type:
- Article
Melanoma: More Answers, More Questions.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 658, doi. 10.1634/theoncologist.2013-0212
- By:
- Publication type:
- Article
A Passion for Solving the Puzzle of Cancer: Jane Cooke Wright, M.D., 1919-2013.
- Published in:
- 2013
- By:
- Publication type:
- Obituary
Efficacy and Economic Value of Adjuvant Imatinib for Gastrointestinal Stromal Tumors.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 689, doi. 10.1634/theoncologist.2012-0474
- By:
- Publication type:
- Article
Ipilimumab for Patients With Advanced Mucosal Melanoma.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 726, doi. 10.1634/theoncologist.2012-0464
- By:
- Publication type:
- Article
Erratum: Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 717, doi. 10.1634/theoncologist.2012-0391
- By:
- Publication type:
- Article
Personalized Cancer Care Is Not New.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 644, doi. 10.1634/theoncologist.2013-0203
- By:
- Publication type:
- Article
Personalized Medicine: Does the Molecular Suit Fit?
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 653, doi. 10.1634/theoncologist.2013-0191
- By:
- Publication type:
- Article
Personalized Cancer Medicine: AreWeThere Yet?
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 649, doi. 10.1634/theoncologist.2013-0189
- By:
- Publication type:
- Article
Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 685, doi. 10.1634/theoncologist.2012-0461
- By:
- Publication type:
- Article
The NOMS Framework: Approach to the Treatment of Spinal Metastatic Tumors.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 744, doi. 10.1634/theoncologist.2012-0293
- By:
- Publication type:
- Article
Predictors of Long-Term Opioid TreatmentAmongPatientsWho Receive Chemoradiation for Head and Neck Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 768, doi. 10.1634/theoncologist.2013-0001
- By:
- Publication type:
- Article
Ipilimumab and Its Toxicities: A Multidisciplinary Approach.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 733, doi. 10.1634/theoncologist.2012-0483
- By:
- Publication type:
- Article
An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 661, doi. 10.1634/theoncologist.2012-0129
- By:
- Publication type:
- Article
Erratum: Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Cancer Clinical Trials-Do We Need a New Algorithm in the Age of Stratified Medicine?
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 651, doi. 10.1634/theoncologist.2013-0190
- By:
- Publication type:
- Article
Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 667, doi. 10.1634/theoncologist.2012-0350
- By:
- Publication type:
- Article
Personalized Medicine: Hype or Reality.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 640, doi. 10.1634/theoncologist.2013-0210
- By:
- Publication type:
- Article
Oncology Comparative Effectiveness Research:A Multistakeholder Perspective on Principles for Conduct and Reporting.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 760, doi. 10.1634/theoncologist.2012-0386
- By:
- Publication type:
- Article
In This Issue: Personalized Medicine.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 639, doi. 10.1634/theoncologist.2013-0211
- By:
- Publication type:
- Article
Comparative Effectiveness Research in Oncology.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 752, doi. 10.1634/theoncologist.2012-0445
- By:
- Publication type:
- Article
Genomics of Squamous Cell Lung Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 707, doi. 10.1634/theoncologist.2013-0063
- By:
- Publication type:
- Article
Progress in the Biological Understanding and Management of Breast Cancer-Associated Central Nervous System Metastases.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 675, doi. 10.1634/theoncologist.2012-0438
- By:
- Publication type:
- Article
Preparing for Success With Comparative Effectiveness Research.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 655, doi. 10.1634/theoncologist.2013-0213
- By:
- Publication type:
- Article